BRAF and cancer: Similar to that observed for TCGA’s BRAF V600E positive samples (Figure S3A,B), negative BL samples had an overall higher expression of cancer-related genes and pathways when compared to negative RL, particularly the PI3K, JAK/STAT, and MAPK pathways (Figure 8A).